HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy

Overview of attention for article published in Frontiers in immunology, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 2 news outlets
twitter: 8 X users

patent: 1 patent

Citations

dimensions_citation: 61 Dimensions

Readers on

mendeley: 163 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

[ BINTAI ] COVID Vaccine with Generex Could Outperform Competition

I3investor, 15 Sep 2020

The below Analyst Report is Exactly the reason why BINTAI is surging today, and will continue to surge https://seekingalpha.com/a…

Generex Biotechnology's COVID-19 Vaccine Could Outperform Competition

Seeking Alpha, 08 Sep 2020

Summary Generex Biotechnology's COVID-19 vaccine is potentially superior to leading competition.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.